Literature DB >> 15384170

Selection of pediatric candidates under the PELD system.

Sue V McDiarmid1, Robert M Merion, Dawn M Dykstra, Ann M Harper.   

Abstract

1. The PELD score accurately predicts the 3 month probability of waiting list death for children with chronic liver disease. 2. Comparing pre and post PELD and MELD implementation, the percent of children receiving deceased donor livers increased and the percent of children dying on the list decreased after PELD/MELD implementation. 3. Excluding children transplanted at status 1, the largest percentage of children are transplanted at a PELD score < 10. 4. Before MELD/PELD 48% of all children receiving deceased donor organs were transplanted at status 1, compared to 41% in the PELD/MELD era. Wide regional variation occurs.

Entities:  

Mesh:

Year:  2004        PMID: 15384170     DOI: 10.1002/lt.20272

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  20 in total

1.  Hepatocellular telomere length in biliary atresia measured by Q-FISH.

Authors:  Yukihiro Sanada; Junko Aida; Youichi Kawano; Ken-ichi Nakamura; Naotaka Shimomura; Naoshi Ishikawa; Tomio Arai; Steven S S Poon; Naoya Yamada; Noriki Okada; Taiichi Wakiya; Makoto Hayashida; Takeshi Saito; Satoshi Egami; Shuji Hishikawa; Yoshiyuki Ihara; Taizen Urahashi; Koichi Mizuta; Yoshikazu Yasuda; Hideo Kawarasaki; Kaiyo Takubo
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

2.  Does the pediatric end-stage liver disease score or hepatic artery resistance index predict outcome after liver transplantation for biliary atresia?

Authors:  Sonal Asthana; Patricia McClean; Mark D Stringer
Journal:  Pediatr Surg Int       Date:  2006-08-01       Impact factor: 1.827

Review 3.  Current developments in pediatric liver transplantation.

Authors:  Christina Hackl; Hans J Schlitt; Michael Melter; Birgit Knoppke; Martin Loss
Journal:  World J Hepatol       Date:  2015-06-18

4.  The efficacy of measurement of the serum beta-D glucan in the patients with biliary atresia.

Authors:  Yukihiro Sanada; Koichi Mizuta; Taizen Urahashi; Yoshiyuki Ihara; Taiichi Wakiya; Noriki Okada; Naoya Yamada; Yoshikazu Yasuda; Hideo Kawarasaki
Journal:  Pediatr Surg Int       Date:  2012-08-19       Impact factor: 1.827

Review 5.  Kidney, pancreas and liver allocation and distribution in the United States.

Authors:  J M Smith; S W Biggins; D G Haselby; W R Kim; J Wedd; K Lamb; B Thompson; D L Segev; S Gustafson; R Kandaswamy; P G Stock; A J Matas; C J Samana; E F Sleeman; D Stewart; A Harper; E Edwards; J J Snyder; B L Kasiske; A K Israni
Journal:  Am J Transplant       Date:  2012-11-16       Impact factor: 8.086

6.  Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?

Authors:  Behairy El-Sayed Behairy; Mostafa Mohamed Sira; Khaled Refat Zalata; El-Sayed Ebrahem Salama; Mohamed Ahmed Abd-Allah
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

Review 7.  Pediatric liver transplantation.

Authors:  Marco Spada; Silvia Riva; Giuseppe Maggiore; Davide Cintorino; Bruno Gridelli
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

8.  Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates.

Authors:  Chung-Chou H Chang; Cindy L Bryce; Benjamin L Shneider; Jonathan G Yabes; Yi Ren; Gabriel L Zenarosa; Heather Tomko; Drew M Donnell; Robert H Squires; Mark S Roberts
Journal:  JAMA Pediatr       Date:  2018-11-01       Impact factor: 16.193

9.  Is the Pediatric End-stage Liver Disease Score Truly a Detriment to Pediatric Liver Allocation?

Authors:  Nadim Mahmud; Melissa M Gadsden; David S Goldberg
Journal:  JAMA Pediatr       Date:  2018-11-01       Impact factor: 16.193

10.  Biliary-Enteric Drainage vs Primary Liver Transplant as Initial Treatment for Children With Biliary Atresia.

Authors:  Elyse LeeVan; Lea Matsuoka; Shu Cao; Susan Groshen; Sophoclis Alexopoulos
Journal:  JAMA Surg       Date:  2019-01-01       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.